Research Division of Labor for the Application Value of Triethanolamine Cream Combined with Recombinant Collagen Dressing in the Management of Radiation-Induced Skin Injury

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600124439

Enrollment

Unknown

Registered

2026-05-12

Start date

2026-05-22

Completion date

Unknown

Last updated

2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Control Group:Triethanolamine Cream

Experimental Group:Recombinant Collagen Dressing

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with pathologically confirmed malignant breast tumors who are scheduled to receive radiation therapy; 2. Age >= 18 years old; 3. KPS score >= 70 points; 4. No previous injury, infection, or allergy history in the irradiated skin area; 5. Patients and their family members are informed of the study and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients who are allergic to triethanolamine cream, recombinant collagen dressing or its components;? 2.Patients with severe cognitive impairment or language communication disorders;? 3. Patients with mental illnesses;? 4. Patients who cannot cooperate to complete the study.

Design outcomes

Primary

Measure	Time frame
Severity of Skin Injury;	—

Secondary

Measure	Time frame
Quality of life score;Investigation of anxiety state;	—

Countries

China

Contacts

Public ContactYu Zongyan

The Second Affiliated Hospital, Air Force Medical University

474232792@qq.com+86 29 8477 7613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026